Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 09, 2022

SELL
$0.81 - $1.17 $81 - $117
-100 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$0.81 - $1.33 $81 - $133
100 New
100 $0

Others Institutions Holding PLX

About Protalix BioTherapeutics, Inc.


  • Ticker PLX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,753,400
  • Market Cap $86.6M
  • Description
  • Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...
More about PLX
Track This Portfolio

Track Rinkey Investments Portfolio

Follow Rinkey Investments and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rinkey Investments, based on Form 13F filings with the SEC.

News

Stay updated on Rinkey Investments with notifications on news.